Literature DB >> 32372406

Contraction-regulated mTORC1 and protein synthesis: Influence of AMPK and glycogen.

Jonas R Knudsen1, Zhencheng Li1, Kaspar W Persson1, Jingwen Li1, Carlos Henriquez-Olguin1, Thomas E Jensen1.   

Abstract

KEY POINTS: AMP-activated protein kinase (AMPK)-dependent Raptor Ser792 phosphorylation does not influence mechanistic target of rapamycin complex 1 (mTORC1)-S6K1 activation by intense muscle contraction. α2 -AMPK activity-deficient mice have lower contraction-stimulated protein synthesis. Increasing glycogen activates mTORC1-S6K1. Normalizing muscle glycogen content rescues reduced protein synthesis in AMPK-deficient mice. ABSTRACT: The mechansitic target of rapamycin complex 1 (mTORC1)-S6K1 signalling pathway regulates muscle growth-related protein synthesis and is antagonized by AMP-activated protein kinase (AMPK) in multiple cell types. Resistance exercise stimulates skeletal muscle mTORC1-S6K1 and AMPK signalling and post-contraction protein synthesis. Glycogen inhibits AMPK and has been proposed as a pro-anabolic stimulus. The present study aimed to investigate how muscle mTORC1-S6K1 signalling and protein synthesis respond to resistance exercise-mimicking contraction in the absence of AMPK and with glycogen manipulation. Resistance exercise-mimicking unilateral in situ contraction of musculus quadriceps femoris in anaesthetized wild-type and dominant negative α2 AMPK kinase dead transgenic (KD-AMPK) mice, measuring muscle mTORC1 and AMPK signalling immediately (0 h) and 4 h post-contraction, and protein-synthesis at 4 h. Muscle glycogen manipulation by 5 day oral gavage of the glycogen phosphorylase inhibitor CP316819 and sucrose (80 g L-1 ) in the drinking water prior to in situ contraction. The mTORC1-S6K1 and AMPK signalling axes were coactivated immediately post-contraction, despite potent AMPK-dependent Ser792 phosphorylation on the mTORC1 subunit raptor. KD-AMPK muscles displayed normal mTORC1-S6K1 activation at 0 h and 4 h post-exercise, although there was impaired contraction-stimulated protein synthesis 4 h post-contraction. Pharmacological/dietary elevation of muscle glycogen content augmented contraction-stimulated mTORC1-S6K1-S6 signalling and rescued the reduced protein synthesis-response in KD-AMPK to wild-type levels. mTORC-S6K1 signalling is not influenced by α2 -AMPK during or after intense muscle contraction. Elevated glycogen augments mTORC1-S6K1 signalling. α2 -AMPK-deficient KD-AMPK mice display impaired contraction-induced muscle protein synthesis, which can be rescued by normalizing muscle glycogen content.
© 2020 The Authors. The Journal of Physiology © 2020 The Physiological Society.

Entities:  

Keywords:  AMPK; glycogen; mTORC1; protein synthesis; resistance exercise; skeletal muscle

Mesh:

Substances:

Year:  2020        PMID: 32372406     DOI: 10.1113/JP279780

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  4 in total

1.  Exercise increases phosphorylation of the putative mTORC2 activity readout NDRG1 in human skeletal muscle.

Authors:  Jonas R Knudsen; Kaspar W Persson; Jaroslawna Meister; Christian S Carl; Steffen H Raun; Nicoline R Andersen; Lykke Sylow; Bente Kiens; Thomas E Jensen; Erik A Richter; Maximilian Kleinert
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-12-06       Impact factor: 4.310

2.  Carbohydrate-Induced Insulin Signaling Activates Focal Adhesion Kinase: A Nutrient and Mechanotransduction Crossroads.

Authors:  Dylan T Wilburn; Steven B Machek; Thomas D Cardaci; Darryn S Willoughby
Journal:  Nutrients       Date:  2020-10-15       Impact factor: 5.717

Review 3.  How Postural Muscle Senses Disuse? Early Signs and Signals.

Authors:  Boris S Shenkman
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

Review 4.  Post-Translational Modifications of the Energy Guardian AMP-Activated Protein Kinase.

Authors:  Ashley J Ovens; John W Scott; Christopher G Langendorf; Bruce E Kemp; Jonathan S Oakhill; William J Smiles
Journal:  Int J Mol Sci       Date:  2021-01-27       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.